ClinicalTrials.gg
RecruitingNCT02235623ORCAUpdated Apr 15, 2026

Orchidopexy Randomized Clinical Assessment

An interventional study of Single-stage Fowler-Stephens orchidopexy (FSO) and Two-stage Fowler-Stephens orchidopexy (FSO) in Unilateral Cryptorchidism, sponsored by Boston Children's Hospital. Recruiting at 1 site in United States. Open to male participants aged 4 Months to 36 Months. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
4 Months to 36 Months
Sex
Male
01

Study summary

This is a randomized trial designed to evaluate testicular outcomes after a single stage versus a two-stage surgical procedure to fix an undescended, one-sided testicle located in the abdomen. Also to determine and compare the costs, surgical complications and the health related quality of life for the two procedures. Testicular outcomes will be measured using a scrotal ultrasound 6-12 months after the procedure (after the second stage procedure for those randomized to a 2 stage surgery).

02

Conditions studied

  • Unilateral Cryptorchidism

Browse trials for

Keywords

  • Laparoscopic Surgery
  • Orchiopexy
03

In context

Cryptorchidism

40 studies on the registry are indexed under Cryptorchidism; 14 are open to participants now.

This study's planned enrollment of 66 is close to the median of 70 across 26 interventional studies indexed under Cryptorchidism.

Browse Cryptorchidism studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 608 studies on the registry; 147 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Months to 36 Months
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Boys age 4 months to 36 months
  • Undergoing diagnostic laparoscopy for unilateral non-palpable testis, who are found at laparoscopy to have an abdominal undescended testis, in whom a Fowler-Stephens Orchiopexy would be appropriate.

Exclusion criteria

Exclusion Criteria:

  • Age > 36 months
  • Age \< 4 months
  • Bilateral cryptorchidism
  • Solitary testis
  • Findings at laparoscopy for which Fowler-Stephens Orchiopexy would not be indicated
  • Intra-operative mobility of the intra-abdominal testis such that, with no (or minimal) mobilization, the testis is able to reach the contralateral internal ring, without dividing the spermatic vessels.
  • Assessment of whether a single stage primary orchidopexy will be performed, is entirely at the discretion of the attending surgeon.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Other
    Stage 1- Single-stage Fowler-Stephens orchidopexy (FSO)

    Stage 1 single surgery to clip the vessels to the testis, divide the spermatic vessels and bring the testis into the scrotum.

    Procedure: Single-stage Fowler-Stephens orchidopexy (FSO)

  • Other
    Stage 2- Two-stage Fowler-Stephens orchidopexy (FSO)

    Stage 2 2 surgeries: 1st surgery-Clip vessels to testis. 2nd surgery done 6-12 months later, divide the spermatic vessels and bring the testis into the scrotum.

    Procedure: Two-stage Fowler-Stephens orchidopexy (FSO)

Interventions

  • ProcedureSingle-stage Fowler-Stephens orchidopexy (FSO)
  • ProcedureTwo-stage Fowler-Stephens orchidopexy (FSO)
06

What researchers measure

Primary outcomes

  1. To evaluate the volume of the operated testis via ultrasound measurements.

    To evaluate the volume of the operated testis at 6-12 months after single-stage Fowler-Stephens orchidopexy (FSO) (6-12 months after two- stage FSO), as determined by ultrasound measurements. This will be compared to the intra-operative testicular measurements done during the laparoscopy.

    Time frame: 6-12 months after final FSO surgery

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02235623
Responsible party
Caleb Nelson (Caleb Nelson, MD MPH, Boston Children's Hospital) — Principal investigator
First posted
Sep 10, 2014
Start date
Aug 2014
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Apr 15, 2026

Study contacts

Badar Omar, BA
Contact
Badar.Omar@childrens.harvard.edu
617-919-6352
Vera Rodic, MPH
Contact
Vera.Rodic@childrens.harvard.edu
Caleb P Nelson, MD, MPH
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion